All FOXO4-DRI products available through Offline Peptides are HPLC verified and supported by third-party certificate of analysis documentation confirming purity and compound identity prior to fulfillment
Administered subcutaneously 3 to 5 days per week
However, a meta-analysis found no significant difference in SDF levels in infertile men following AOX supplementation as compared to placebo or no treatment (100)
PMID: 12351409
Sources: Novinscak T, Brcic L, Staresinic M, et al
Ramratnam M, Sharma RK, DAuria S, Lee SJ, Wang D, Huang XY, Ahmad F (2014) Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice